Amlodipine, Valsartan, Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 51407-670

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Amlodipine, Valsartan, Hydrochlorothiazide (NDC 51407-670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-668-30 (Rev 09-22.jpg)

51407-668-30 (Rev 09-22.jpg)
Label for Amlodipine/Valsartan/Hydrochlorothiazide film-coated tablets containing 5 mg amlodipine, 160 mg valsartan, and 12.5 mg hydrochlorothiazide per tablet. Pack contains 30 tablets. Label includes storage instructions and manufacturer details, with a National Drug Code (NDC) 51407-668-30. Marketed by GSMS, Incorporated.*
FDA Label Image

51407-669-30 (Rev 09-22.jpg)

51407-669-30 (Rev 09-22.jpg)
Label for Amlodipine/Valsartan/Hydrochlorothiazide film-coated tablets, 5 mg/160 mg/25 mg strength. The label indicates a 30-tablet count bottle. It includes the NDC 51407-669-30, a barcode, and storage instructions. Manufactured by Strides Pharma, marketed by GSMS, Incorporated.*
FDA Label Image

51407-670-30 (Rev 09-22.jpg)

51407-670-30 (Rev 09-22.jpg)
Label for Amlodipine/Valsartan/Hydrochlorothiazide tablets, showing strength of 10 mg/160 mg/12.5 mg. The label indicates a quantity of 30 film-coated tablets, Rx only. Manufactured by Strides Pharma, marketed by GSMS Incorporated. Includes storage instructions, tablet composition, and NDC 51407-670-30.*
FDA Label Image

51407-671-30 (Rev 09-22.jpg)

51407-671-30 (Rev 09-22.jpg)
Label for Amlodipine/Valsartan/Hydrochlorothiazide tablets, strength 10 mg/160 mg/25 mg, film-coated, oral tablets. The label shows the NDC code 51407-671-30, package count of 30 tablets, and manufacturer details for Strides Pharma, Inc., marketed by GSMS, Incorporated. The label includes storage instructions and a barcode.*
FDA Label Image

51407-672-30 (Rev 09-22.jpg)

51407-672-30 (Rev 09-22.jpg)
Label for Amlodipine/Valsartan/Hydrochlorothiazide film-coated tablets, strength 10 mg/320 mg/25 mg, packaged in a bottle containing 30 tablets. The label includes storage instructions, dosage reference, and manufacturer information. It is marketed by GSMS Incorporated and manufactured by Strides Pharma, Inc.*
FDA Label Image

Amlodipine-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 40)

Amlodipine-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 40)
Chemical structure diagram depicting molecular representations of components, including a chlorophenyl-containing compound and a benzene ring with a sulfonic acid group, consistent with chemical features of amlodipine besylate and hydrochlorothiazide ingredients.*
FDA Label Image

Valsartan-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 41)

Valsartan-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 41)
Chemical structure diagram of the active ingredient amlodipine besylate, showing molecular bonds and groups typical to amlodipine's composition.*
FDA Label Image

Hctz-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 42)

Hctz-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 42)
Chemical structure of amlodipine besylate, one of the active ingredients in AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE tablets. The diagram shows the atomic connectivity and key functional groups of the amlodipine besylate molecule.*
FDA Label Image

Figure1 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 43)

Figure1 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 43)
A bar chart titled 'Reduction in Mean Blood Pressure at Endpoint' showing decreases in diastolic and systolic blood pressure for four different treatments listed in the legend. The chart compares values for HCTZ/Aml 25/10, Val/HCTZ 320/25, Aml/Val 10/320, and Aml/Val/NCTZ 10/320/25 with reductions noted on the y-axis.*
FDA Label Image

Figure2 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 44)

Figure2 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 44)
Line graph titled 'Mean Sitting Diastolic Blood Pressure by Treatment and Week' showing changes in mean sitting diastolic blood pressure (mmHg) over an 8-week period for four treatment groups: Aml/Val/HCTZ 10/320/25 mg, Val/HCTZ 320/25 mg, Aml/Val 10/320 mg, and HCTZ/Aml 25/10 mg. The x-axis represents weeks (0 to 8) and the y-axis shows blood pressure values from 80 to 110 mmHg.*
FDA Label Image

Figure3 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 45)

Figure3 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 45)
Line graph titled 'Mean Sitting Systolic Blood Pressure by Treatment and Week' showing mean sitting systolic blood pressure (mmHg) on the vertical axis against weeks on the horizontal axis (0 to 8). The graph compares four treatments with distinct markers: Amlodipine/valsartan/hydrochlorothiazide 10/320/25 mg, Amlodipine/valsartan 10/320 mg, valsartan/hydrochlorothiazide 320/25 mg, and hydrochlorothiazide/amlodipine 25/10 mg. The Amlodipine/valsartan/hydrochlorothiazide 10/320/25 mg treatment shows the largest reduction in mean systolic blood pressure over time.*
FDA Label Image

Figure4 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 46)

Figure4 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 46)
Line chart titled 'Mean Ambulatory Diastolic Blood Pressure at Endpoint by Treatment and Hour' showing mean ambulatory DBP (mmHg) over 24 hours after dosing. The graph compares four treatments: Amlodipine/Valsartan/Hydrochlorothiazide 10/320/25 mg, Valsartan/HCTZ 320/25 mg, Amlodipine/Valsartan 10/320 mg, and HCTZ/Amlodipine 25/10 mg, with DBP values plotted hourly throughout the day.*
FDA Label Image

Figure5 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 47)

Figure5 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 47)
Line graph titled 'Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour' showing mean ambulatory systolic blood pressure (mmHg) over 24 hours after dosing. The graph compares four treatments: Aml/Val/HCTZ 10/320/25 mg, Val/HCTZ 320/25 mg, Aml/Val 10/320 mg, and HCTZ/Aml 25/10 mg, with distinct line styles and markers representing each treatment's blood pressure trends throughout the day.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.